APA (7th ed.) Citation

Lachno, D. R., Evert, B. A., Maloney, K., Willis, B. A., Talbot, J. A., Vandijck, M., & Dean, R. A. (2015). Validation and Clinical Utility of ELISA Methods for Quantification of Amyloid-β of Peptides in Cerebrospinal Fluid Specimens from Alzheimer’s Disease Studies. Journal of Alzheimer's disease, 45(2), 527. https://doi.org/10.3233/JAD-141686

Chicago Style (17th ed.) Citation

Lachno, D Richard, Barbara A. Evert, Kaia Maloney, Brian A. Willis, Jayne A. Talbot, Manu Vandijck, and Robert A. Dean. "Validation and Clinical Utility of ELISA Methods for Quantification of Amyloid-β of Peptides in Cerebrospinal Fluid Specimens from Alzheimer’s Disease Studies." Journal of Alzheimer's Disease 45, no. 2 (2015): 527. https://doi.org/10.3233/JAD-141686.

MLA (9th ed.) Citation

Lachno, D Richard, et al. "Validation and Clinical Utility of ELISA Methods for Quantification of Amyloid-β of Peptides in Cerebrospinal Fluid Specimens from Alzheimer’s Disease Studies." Journal of Alzheimer's Disease, vol. 45, no. 2, 2015, p. 527, https://doi.org/10.3233/JAD-141686.